Three children (two with KMT2A gene rearrangement and one with germline KMT2A) developed relapse through lineage switch to CD19-negative acute myeloid leukemia, mixed phenotypic acute leukemia and unclassifiable leukemia. Here, CD19 is linked to acute leukemia.